|
|
||||||||
-subunit gene
lu, MD
From the Cyprus Institute of Neurology and Genetics (Drs. Middleton, Christodoulou, Neocleous, Zamba, Pantzaris, Kyriallis, and Tsingis), Nicosia, Cyprus; the Department of Neurology and Neuromuscular Research Laboratory (Drs. Ohno, Milone, and Engel, and J. Brengman), Mayo Clinic, Rochester, MN; the Department of Neurology (Drs. Deymeer, Serdaro
lu, and Özdemir), Istanbul University, Turkey; King Hussein Medical Center (Drs. Mubaidin and Horany), Amman, Jordan; the Faculty of Medicine (Dr. Al-Shebab), University of Jordan, Amman, Jordan; and the Neurology Clinic (Drs. Mavromatis and Mylonas), Aristotelion University, Thessaloniki, Greece.
Address correspondence and reprint requests to Dr. A.G. Engel, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.
OBJECTIVE: To identify and to characterize functionally the mutational basis of congenital myasthenic syndromes (CMS) linked to chromosome 17p.
BACKGROUND: A total of 37 patients belonging to 13 CMS families, 9 of them consanguineous, were investigated. All patients were linked previously to the telomeric region of chromosome 17p. Two candidate genes in this region encode synaptobrevin 2, a presynaptic protein, and the
-subunit of the acetylcholine receptor (AChR). Direct sequencing of the synaptobrevin 2 gene revealed no mutations. The authors thus searched for mutations in the
-subunit gene of AChR.
METHODS: Direct sequencing of the AChR
-subunit, restriction analysis, allele-specific PCR, and expression studies in human embryonic kidney cells were performed.
RESULTS: The authors identified two previously characterized and five novel
-subunit gene mutations, all homozygous, in the 13 kinships. Two of the novel mutations are truncating (
723delC and
760ins8), one is a missense mutation in the signal peptide region (
V-13D), one is a missense mutation in the N-terminal extracellular domain (
T51P), and one is a splice donor site mutation in intron 10 (
IVS10+2T
G). Unaffected family members have no mutations or are heterozygous. Expression studies indicate that the four novel mutations in the coding region of the gene and the most likely transcript of the splice-site mutation, which skips exon 10, are low-expressor or null mutations.
CONCLUSIONS: Chromosome 17p-linked congenital myasthenic syndromes are caused by low-expressor/null mutations in the AChR
-subunit gene. Mutations in this gene are a common cause of CMS in eastern Mediterranean countries.
Key words: Congenital myasthenic syndromesChromosome 17pAcetylcholine receptor.
This article has been cited by other articles:
![]() |
P. Richard, K. Gaudon, H. Haddad, A. B. Ammar, E. Genin, S. Bauche, M. Paturneau-Jouas, J. S. Muller, H. Lochmuller, D. Grid, et al. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa Neurology, December 9, 2008; 71(24): 1967 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Ohno, A Tsujino, X-M Shen, M Milone, and A G Engel Spectrum of splicing errors caused by CHRNE mutations affecting introns and intron/exon boundaries J. Med. Genet., August 1, 2005; 42(8): e53 - e53. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Soltanzadeh, J S Muller, A Ghorbani, A Abicht, H Lochmuller, and A Soltanzadeh An Iranian family with congenital myasthenic syndrome caused by a novel acetylcholine receptor mutation (CHRNE K171X) J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 1039 - 1040. [Full Text] [PDF] |
||||
![]() |
J. S. Muller, G. Mildner, W. Muller-Felber, U. Schara, K. Krampfl, B. Petersen, S. Petrova, R. Stucka, W. Mortier, J. Bufler, et al. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients Neurology, June 10, 2003; 60(11): 1805 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ealing, R. Webster, S. Brownlow, A. Abdelgany, H. Oosterhuis, F. Muntoni, D. J. Vaux, A. Vincent, and D. Beeson Mutations in congenital myasthenic syndromes reveal an {varepsilon} subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR Hum. Mol. Genet., November 15, 2002; 11(24): 3087 - 3096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |